drugset / Trial / NCT01138514

Clinical Study Between Two Clindamycin 1%/Benzoyl Peroxide 5% Topical Gels

NCT01138514

Phase 3 Completed 1555 enrolled Padagis LLC
RandomizedParallel-groupDouble-blindTreatment

Summary

The purpose of this study is to compare the efficacy and safety profiles of Perrigo Israel Pharmaceuticals, Ltd. Clindamycin 1%/Benzoyl Peroxide 5% Topical Gel and Benzaclin® Topical Gel (Clindamycin- Benzoyl Peroxide Gel).

Timeline

Start
2009-10
Primary completion
2010-10
Completion
2010-10

Drugs

EvaluationDrugModalityDoseRoute
Comparator Benzoyl Peroxide Other / unclassified 5 % Topical
Comparator Clindamycin Unknown 1 % Topical

Indications